Latest news
BioNTech's New Era: A CEO Handover, a €613 Million Lifeline, and the Cost of Letting Go - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 00:42:49 GMTBioNTech Names Industry Veteran Guido Oelkers as New CEO in Major Leadership Transition - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 11:30:00 GMTBioNTech Reports Second-Quarter 2026 Results, Advances Oncology Pipeline and Appoints Guido Oelkers as Next CEO - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 10:51:00 GMTAfter 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA company - Fierce BiotechFierce Biotech · Mon, 03 Aug 2026 11:35:29 GMTBioNTech (Nasdaq: BNTX) taps Guido Oelkers to succeed Ugur Sahin as CEO - Stock TitanStock Titan · Mon, 03 Aug 2026 10:54:42 GMTGuido Oelkers will replace Ugur Sahin at the helm of BioNTech in 2027 - DemócrataDemócrata · Mon, 03 Aug 2026 09:44:46 GMTBioNTech CEO Ugur Sahin to depart, Guido Oelkers to succeed - TipRanksTipRanks · Mon, 03 Aug 2026 09:08:54 GMTBioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer - Enidnews.comEnidnews.com · Mon, 03 Aug 2026 09:00:55 GMT